Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Media Industry Observer.
Press releases published on October 25, 2025
Where to Buy Kratom Online: Kratom Bird Stands Out Among the Best Kratom Brands in Europe
London, UK, Oct. 25, 2025 (GLOBE NEWSWIRE) -- Kratom Bird announces its position as a leading destination for Europeans seeking premium, transparently sourced, and responsibly distributed kratom. With a customer-first philosophy, meticulous batch controls, …
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Jasper Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – JSPR
NEW YORK, Oct. 25, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Jasper Therapeutics, Inc. (NASDAQ: JSPR) between November 30, 2023 and July 3, 2025, both dates inclusive (the “Class …
AlphaTON Capital and Cyncado Therapeutics Share New Mesothelioma Data Supporting TT-4’s Path to First- Patient Dosing
Dover, DE, Oct. 25, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp (Nasdaq: ATON) and its wholly owned oncology-focused subsidiary Tarus Therapeutics, LLC, operating as Cyncado Therapeutics, today announced that a new poster is live at the AACR-NCI-EORTC …
Preclinical Data Presented at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Support Potential of BBO-10203, a First-in-Class RAS:PI3Kα Breaker That Inhibits KRAS-Mutant Tumor Growth without Inducing…
Data demonstrate BBO-10203 blocks RAS-mediated activation of PI3Kα and strongly inhibits pAKT signaling in tumor cells without affecting glucose metabolism Robust monotherapy activity, as well as combination activity with BBOT’s KRASG12C ON/OFF inhibitor, …
CRISPR Gene Editing Market to Hit $12.78B by 2033, Kits & Reagents 60.5% Share, Cas9 Drives Innovation
CRISPR Gene Editing Industry Forecast | Market $12.78B by 2033, North America Leads 48.5% AUSTIN, TX, UNITED STATES, October 25, 2025 /EINPresswire.com/ -- CRISPR Gene Editing: A Technological Overview CRISPR gene editing has transitioned from a …
United States Bioresorbable Polymers Market is expected to reach USD 3.3 billion by 2031 | DataM Intelligence
The Global Bioresorbable Polymers Market is expected to reach at a CAGR of 13.4% during the forecast period 2024-2031. AUSTIN, TX, UNITED STATES, October 25, 2025 /EINPresswire.com/ -- Overview of the Market: The Global Bioresorbable Polymers Market …
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages KBR, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – KBR
NEW YORK, Oct. 25, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of KBR, Inc. (NYSE: KBR) between May 6, 2025 and June 19, 2025, both dates inclusive (the “Class Period”), of the important …
Cullinan Therapeutics Shares Additional Preclinical B Cell Depletion Data for CLN-978, Supporting Clinical Development Across Multiple Autoimmune Diseases, at ACR Convergence 2025
CLN-978 led to rapid and deep B cell depletion in vitro and in vivo in multiple autoimmune diseases CAMBRIDGE, Mass., Oct. 25, 2025 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a clinical-stage biopharmaceutical company accelerating …
Data presented at ACR Convergence 2025 highlight Sobi’s commitment to advancing care across rare and underserved inflammatory conditions
NASP data highlight reduction in disease burden among people living with uncontrolled gout Gamifant (emapalumab) data showed response rates in patients with MAS in Still’s disease across MAS subtypes, including in those with recurrent disease Discussion of …
congatec Showcases AI, IoT and Embedded Edge Computing Platforms at embedded world North America
congatec drives attendance with free exhibit hall pass, $50 value SAN DIEGO, CA, UNITED STATES, October 24, 2025 /EINPresswire.com/ -- congatec — a leading vendor of embedded and edge computing technology — will share its latest developments in embedded …
Quell Therapeutics to Unveil Promising Data for QEL-005, a Novel CAR-Treg Cell Therapy for Complex Autoimmune Diseases, at ACR Convergence 2025
Results from pre-clinical studies demonstrate immunomodulatory activity of QEL-005 across multiple immune cell lineages involved in complex autoimmune inflammation, including B cells, T cells and inflammatory macrophages Broad mechanism of action of QEL- …
Kyverna Therapeutics Highlights Potential of KYV-101 in Rheumatoid Arthritis with Phase 1 Data from Investigator-Initiated Trial Presented at ACR Convergence 2025
KYV-101 resulted in a profound reduction in disease-associated autoantibodies and impact on disease activity in patients with difficult-to-treat rheumatoid arthritis (RA) KYV-101 continues to demonstrate a well-tolerated profile, consistent with …
Bittam Launches $3,000 New User Reward Program No funding fee No slippage and Expands 200× Leverage Trading
NEW YORK, Oct. 25, 2025 (GLOBE NEWSWIRE) -- Bittam Exchange, a rapidly emerging global cryptocurrency derivatives platform, today announced the launch of its New User Reward Program, offering traders up to $3,000 in bonuses as part of a broader initiative …